The Danon Disease Treatment Industry is entering a transformative era as of 2025. This rare, X-linked genetic disorder—caused by mutations in the LAMP2 gene—primarily affects young males, leading to severe cardiomyopathy, skeletal myopathy, and cognitive impairment. Historically, the only definitive "treatment" was heart transplantation. However, recent...